Home/Filings/4/0001209191-18-025824
4//SEC Filing

Torres S. Edward 4

Accession 0001209191-18-025824

CIK 0001718108other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 4:16 PM ET

Size

14.4 KB

Accession

0001209191-18-025824

Insider Transaction Report

Form 4
Period: 2018-04-23
Transactions
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total(indirect: By Fund)
    Common Stock (3,181,817 underlying)
  • Conversion

    Common Stock

    2018-04-23+3,181,8173,181,817 total(indirect: By Fund)
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+266,000$3,990,0003,447,817 total(indirect: By Fund)
Transactions
  • Conversion

    Common Stock

    2018-04-23+3,181,8173,181,817 total(indirect: By Fund)
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total(indirect: By Fund)
    Common Stock (3,181,817 underlying)
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+266,000$3,990,0003,447,817 total(indirect: By Fund)
Transactions
  • Conversion

    Common Stock

    2018-04-23+3,181,8173,181,817 total(indirect: By Fund)
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+266,000$3,990,0003,447,817 total(indirect: By Fund)
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total(indirect: By Fund)
    Common Stock (3,181,817 underlying)
Transactions
  • Conversion

    Common Stock

    2018-04-23+3,181,8173,181,817 total(indirect: By Fund)
  • Purchase

    Common Stock

    2018-04-23$15.00/sh+266,000$3,990,0003,447,817 total(indirect: By Fund)
  • Conversion

    Series A Preferred Stock

    2018-04-237,000,0000 total(indirect: By Fund)
    Common Stock (3,181,817 underlying)
Footnotes (2)
  • [F1]The Series A Preferred Stock automatically converted into the Issuer's common stock on a 2.2-for-1 basis at the closing of the Issuer's initial public offering without payment or further consideration and had no expiration date.
  • [F2]These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which consists of S. Edward Torres, Dr. Steven E. Hall and Dr. Armen B. Shanafelt. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares held by LVFI, except to the extent of his or its pecuniary interest therein. Dr. Shanafelt is a director of the Issuer and, accordingly, files separate Section 16 reports.

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1
  • filerCIK 0001552293

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 4:16 PM ET
Size
14.4 KB